Top

Gepubliceerd in:

2020 | OriginalPaper | Hoofdstuk

7. Maag-, darm- en leverziekten

Auteurs : Dr. Tanya Bisseling, Dr. Sander van der Marel, Dr. Annemarie Boleij, Drs. Carlijn Bruggeling, Drs. Menso Westerouen van Meeteren

Gepubliceerd in: Handboek leefstijlgeneeskunde

Uitgeverij: Bohn Stafleu van Loghum

Samenvatting

In geen enkel orgaansysteem komen gezondheid en ziekte dichter bij ‘voeding en leefstijl’ dan in het maag-darmstelsel. In het maag-darmstelsel kunnen voeding en leefstijl zowel het ontstaan als het beloop van ziekten in de verschillende organen beïnvloeden. In sommige gevallen heeft het ontstaan van ziekte/klachten duidelijk een relatie met specifieke voedingsstoffen en spelen leefstijlinterventies nauwelijks een rol. Bij andere aandoeningen spelen naast voeding ook leefstijlfactoren een rol bij het ontstaan en behandelen. Voor een derde groep aandoeningen is de relatie met voeding en leefstijl nog niet evident. Daarnaast is het microbioom een onmisbaar onderdeel van het maag-darmstelsel. Van sommige micro-organismen is bekend dat zij de kans op het ontwikkelen van ziekten kunnen vergroten. Beïnvloeding van het microbioom door voedings- en leefstijlinterventies kan positieve en negatieve effecten hebben op de gezondheid. In dit hoofdstuk ligt de focus, behalve op de invloed van het microbioom, op de meest voorkomende aandoeningen van het maag-darmstelsel waarbij een combinatie van voeding en leefstijl een rol speelt.

vorige hoofdstuk Nierziekte

volgende hoofdstuk Kanker

Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017). Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut, 66(6), 1138–1153.

Agus, A., Planchais, J., & Sokol, H. (2018). Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host & Microbe, 23(6), 716–724. https://doi.org/10.1016/j.chom.2018.05.003.

Ajmera, V., Belt, P., Wilson, L. A., Gill, R. M., Loomba, R., Kleiner, D. E., et al. (2018). Among patients with nonalcoholic fatty liver disease, modest alcohol use is associated with less improvement in histologic steatosis and steatohepatitis. Clinical Gastroenterology and Hepatology: the official clinical practice journal of the American Gastroenterological Association, 16(9), 1511–20.e5.

Andriulli, A., Botteri, E., Almasio, P. L., et al. (2010). Smoking as a cofactor for causation of chronic pancreatitis: A meta-analysis. Pancreas, 39, 1205–1210.

Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A., Feldstein, A. F., & Zein, N. N. (2010). The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology (Baltimore, MD), 51(6), 1972–1978.

Bager, P., Wohlfahrt, J., & Westergaard, T. (2008). Caesarean delivery and risk of atopy and allergic disease: Meta-analyses. Clinical and Experimental Allergy, 38, 634–642.

Baumgart, D. C., & Sandborn, W. J. (2012). Crohn’s disease. Lancet, 380(9853), 1590–1605. https://doi.org/10.1016/S0140-6736(12)60026-9.

Casas, R., Sacanella, E., & Estruch, R. (2014). The immune protective effect of the Mediterranean diet against chronic low-grade inflammatory diseases. Endocrine, Metabolic & Immune Disorders: Drug Targets, 14, 245–254.

Casas, R., Sacanella, E., Urpi-Sarda, M., et al. (2016). Long-term immunomodulatory effects of a mediterranean diet in adults at high risk of cardiovascular disease in the PREvencion con DIeta MEDiterranea (PREDIMED) Randomized Controlled Trial. Journal of Nutrition, 146, 1684–1693.

Conlon, M. A., & Bird, A. R. (2014). The impact of diet and lifestyle on gut microbiota and human health. Nutrients, 7(1), 17–44. https://doi.org/10.3390/nu7010017.

Couturier-Maillard, A., Secher, T., Rehman, A., et al. (2013). NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. Journal of Clinical Investigation, 123(2), 700–711. https://doi.org/10.1172/JCI62236.

Cryan, J. F., & Dinan, T. G. (2012). Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience, 13(10), 701–712. https://doi.org/10.1038/nrn3346.

Enrique Dominguez-Munoza, J., Drewes b, A. M., Lindkvist, B., Ewald, N., Czako, L., Rosendahl, J., et al. (2018). Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis. Pancreatology, 18, 847e854.

Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M. I., Corella, D., Arós, F., et al. (2018). Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts. The New England Journal of Medicine, 378(25), e34. https://doi.org/10.1056/NEJMoa1800389.

Forbes, A., Escher, J., Hébuterne, X., Kłęk, S., Krznaric, Z., Schneider, S., et al. (2017). ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clinical Nutrition, 36(2), 321–347. https://doi.org/10.1016/j.clnu.2016.12.027.

Gepner, Y., Shelef, I., Komy, O., Cohen, N., Schwarzfuchs, D., Bril, N., et al. (2019). The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content. Journal of Hepatology, 71(2), 379–388.

Gibson, P. R., Varney, J., Malakar, S., & Muir, J. G. (2015). Food components and irritable bowel syndrome. Gastroenterology, 148, 1158–1174.

Gleeson, M., Bishop, N. C., Stensel, D. J., Lindley, M. R., Mastana, S. S., & Nimmo, M. A. (2011). The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease. Nature Reviews Immunology, 11(9), 607–615. https://doi.org/10.1038/nri3041.

Han, S., Patel, B., Min, M., Bocelli, L., Kheder, J., Wachholtz, A., et al. (2018). Quality of life comparison between smokers and non-smokers with chronic pancreatitis. Pancreatology, 18, 269e274.

Haverkort, E. B., Binnekade, J. M., De Haan, R. J., Busch, O. R. C., Van Berge Henegouwen, M. I., & Gouma, D. J. (2012). Suboptimal intake of nutrients after esophagectomy with gastric tube reconstruction. Journal of the Academy of Nutrition and Dietetics, 112(7), 1080–1087.

Hester, D., Golabi, P., Paik, J., Younossi, I., Mishra, A., & Younossi, Z. M. (2019). Among medicare patients with hepatocellular carcinoma, non-alcoholic fatty liver disease is the most common etiology and cause of mortality. Journal of clinical gastroenterology, 3(11), 1459–1471.

Holtmann, G. J., Ford, A. C., & Talley, N. J. (2016). Pathophysiology of irritable bowel syndrome. The Lancet Gastroenterology & Hepatology, 1(2), 133–146. https://doi.org/10.1016/S2468-1253(16)30023-1.

Kaltenbach, T., Crockett, S., & Gerson, L. B. (2006). Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Archives of Internal Medicine, 166, 965–971.

Kaser, A., Zeissig, S., & Blumberg, R. S. (2010). Inflammatory bowel disease. Annual Review of Immunology, 28, 573–621.

King, J. A., Underwood, F. E., Panaccione, N., Quan, J., Windsor, J. W., Kotze, P. G., et al. (2019). Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: A population-based study of countries in the Organisation for Economic Co-operation and Development. The Lancet Gastroenterology & Hepatology, 4(4), 287–295. https://doi.org/10.1016/S2468-1253(19)30013-5.

Krzizek, E.-C., Brix, J. M., Herz, C. T., Kopp, H. P., Schernthaner, G.-H., Schernthaner, G., et al. (2018). Prevalence of micronutrient deficiency in patients with morbid obesity before bariatric surgery. Obesity Surgery, 28, 643–648. https://doi.org/10.1007/s11695-017-2902-4.

Langdon, A., Crook, N., & Dantas, G. (2016). The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Medicine, 8(1), 39. https://doi.org/10.1186/s13073-016-0294-z.

Lee, D., Albenberg, L., Compher, C., Baldassano, R., Piccoli, D., Lewis, J. D., et al. (2015). Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology, 148(6), 1087–1106. https://doi.org/10.1053/j.gastro.2015.01.007.

Limketkai, B. N., Iheozor-Ejiofor, Z., Gjuladin-Hellon, T., Parian, A., Matarese, L. E., Bracewell, K., et al. (2019). Dietary interventions for induction and maintenance of remission in inflammatory bowel disease. Cochrane Database Systamatic Review, 2, 2839. https://doi.org/10.1002/14651858.CD012839.pub2.

Luukkonen, P. K., Sädevirta, S., Zhou, Y., Kayser, B., Ali, A., Ahonen, L., et al. (2018). Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars. Diabetes care, 41(8), 1732–1739.

Maynard, C. L., Elson, C. O., Hatton, R. D., & Weaver, C. T. (2012). Reciprocal interactions of the intestinal microbiota and immune system. Nature, 489(7415), 231–241. https://doi.org/10.1038/nature11551.

Mena, M. P., Sacanella, E., Vazquez-Agell, M., et al. (2009). Inhibition of circulating immune cell activation: a molecular antiinflammatory effect of the Mediterranean diet. American Journal of Clinical Nutrition, 89, 248–256.

Ordás, I., Eckmann, L., Talamini, M., Baumgart, D. C., & Sandborn, W. J. (2012). Ulcerative colitis. Lancet, 380(9853), 1606–1619. https://doi.org/10.1016/S0140-6736(12)60150-0.

Palleja, A., Mikkelsen, K. H., Forslund, S. K., Kashani, A., Allin, K. H., Nielsen, T., et al. (2018). Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature Microbiology, 3, 1255–1265.

Parkar, S. G., Kalsbeek, A., & Cheeseman, J. F. (2019). Potential role for the gut microbiota in modulating host circadian rhythms and metabolic health. Microorganisms, 7(2), 41. https://doi.org/10.3390/microorganisms7020041.

Patel, V., & Sanyal, A. J. (2013). Drug-induced steatohepatitis. Clinics in Liver Disease 17(4), 533–46, vii.

Piovani, D., Danese, S., Peyrin-Biroulet, L., Nikolopoulos, G. K., Lytras, T., & Bonovas, S. (2019). Environmental risk factors for inflammatory bowel diseases: An umbrella review of meta-analyses. Gastroenterology, 157(3), 647–659.e4.

Romagnuolo, J., Talluri, J., Kennard, E., Sandhu, B. S., Sherman, S., Cote, G. A., et al. (2016). Clinical Profile, Etiology, and Treatment of Chronic Pancreatitis in North American Women Analysis of a Large Multicenter Cohort. Pancreas, 45(7), 934–940.

Rome Foundation (2019). https://theromefoundation.org/rome-iv/.

Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017). Treatment of NAFLD with diet, physical activity and exercise. Journal of Hepatology, 67(4), 829–846.

Schumann, D., Klose, P., Lauche, R., Dobos, G., Langhorst, J., & Cramer, H. (2018a). Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. Nutrition, 45, 24–31. https://doi.org/10.1016/j.nut.2017.07.004.

Schumann, D., Langhorst, J., Dobos, G., & Cramer, H. (2018b). Randomised clinical trial: Yoga vs a low-FODMAP diet in patients with irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 47(2), 203–211. https://doi.org/10.1111/apt.14400.

Singh, S., Dulai, P. S., Zarrinpar, A., Ramamoorthy, S., & Sandborn, W. J. (2017). Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nature Reviews Gastroenterology & Hepatology, 14(2), 110–121. https://doi.org/10.1038/nrgastro.2016.181.

Singhvi, A., & Yadav, D. (2018). Myths and realities about alcohol and smoking in chronic pancreatitis. Current Opinion in Gastroenterology, 34, 355–361. https://doi.org/10.1097/MOG.0000000000000466.

Stein, E. M., & Silverberg, S. J. (2014). Bone loss after bariatric surgery: Causes, consequences, and management. Lancet Diabetes Endocrinol 2(2), 165e74.

Stein, J., Stier, C., Raab, H., & Weiner, R. (2014). The nutritional and pharmacological consequences of obesity surgery. Alimentary Pharmacology & Therapeutics, 40(6), 582e609.

Thibault, R., Huber, O., Azagury, D. E., & Pichard, C. (2016). Twelve key nutritional issues in bariatric surgery. Clinical Nutrition, 35, 12e17.

Torres, J., Ellul, P., Langhorst, J., Mikocka-Walus, A., Barreiro-de Acosta, M., Basnayake, C., et al. (2019). European Crohn’s and colitis organisation topical review on complementary medicine and psychotherapy in inflammatory bowel disease. Journal of Crohn’s and Colitis, 13(6), 673–685e. https://doi.org/10.1093/ecco-jcc/jjz051.

Tremaroli, V., A., Karlsson, F., Werling, M., Le Roux, C. W., Nielsen, J., Bäckhed, F., et al. (2015). Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metabolism, 22, 228–238.

Valenti, L., Bugianesi, E., Pajvani, U., & Targher, G. (2016). Nonalcoholic fatty liver disease: Cause or consequence of type 2 diabetes? Liver International: official journal of the International Association for the Study of the Liver., 36(11), 1563–1579.

Van den Berg, E. H., Amini, M., Schreuder, T. C., Dullaart, R. P., Faber, K. N., Alizadeh, B. Z., et al. (2017). Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort. PLoS One, 12(2), e0171502.

Van der Waaji, L., & Stevens, J. (2014). FODMAP-beperkt dieet bij prikkelbaredarmsyndroom. Nederlands Tijdschrift voor Geneeskunde, 158, A7407.

Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., et al. (2015). Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology, 149(2), 78.e5; quiz e14-5–78.

Vos, M. B., & Lavine, J. E. (2013). Dietary fructose in nonalcoholic fatty liver disease. Hepatology (Baltimore, MD), 57(6), 2525–2531.

Vrieze, A., Holleman, F., Zoetendal, E. G., De Vos, W. M., Hoekstra, J. B. L., & Nieuwdorp, M. (2010). The environment within: How gut microbiota may influence metabolism and body composition. Diabetologia, 53, 606–613.

Wang, X., Li, J., Riaz, D. R., Shi, G., Liu, C., & Dai, Y. (2014). Outcomes of liver transplantation for nonalcoholic steatohepatitis: A systematic review and meta-analysis. Clinical Gastroenterology and Hepatology: the official clinical practice journal of the American Gastroenterological Association., 12(3), 394–402.e1.

Wong, V. W.-S., Wong, G. L.-H., Chan, R. S.-M., Shu, S. S.-T., Cheung, B. H.-K., Li, L. S., et al. (2018). Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. Journal of hepatology, 69(6), 1349–1356.

Younossi, Z. M., Loomba, R., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander-Tetri, B. A., et al. (2018). Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology (Baltimore, MD), 68(1), 361–371.

Zein, C. O., Unalp, A., Colvin, R., Liu, Y. C., & McCullough, A. J. (2011). Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. Journal of Hepatology, 54(4), 753–759.

Zelber-Sagi, S., Ivancovsky-Wajcman, D., Fliss Isakov, N., Webb, M., Orenstein, D., Shibolet, O., et al. (2018). High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. Journal of Hepatology, 68(6), 1239–1246.

Zhou, C., Zhao, E., Li, Y., Jia, Y., & Li, F. (2019). Exercise therapy of patients with irritable bowel syndrome: A systematic review of randomized controlled trials. Neurogastroenterology & Motility, 31, e13461.

Titel: Maag-, darm- en leverziekten
Auteurs: Dr. Tanya Bisseling
Dr. Sander van der Marel
Dr. Annemarie Boleij
Drs. Carlijn Bruggeling
Drs. Menso Westerouen van Meeteren
Uitgeverij: Bohn Stafleu van Loghum
Boek: Handboek leefstijlgeneeskunde
Print ISBN: 978-90-368-2323-4

Elektronisch ISBN: 978-90-368-2324-1

Copyright: 2020
DOI: https://doi.org/10.1007/978-90-368-2324-1_7

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen